03:48

The Power of Community: Francisco

01:15:35

1211. Community Spotlight | Kim Harrison

29:31

1210. Community Spotlight | Paula Jones

35:22

2024 ADEM Together | Community Q&A

18:58

1209. What is ULTOMIRIS?

58:30

2024 MOGAD Together | Community Q&A

49:26

2024 NMOSD Together | Community Q&A

01:00:23

1208. MOGcast | Understanding Cortical Encephalitis

01:04:50

1207. MOGcast | The Latest in Treatments from an Adult and Pediatric Perspective

33:21

1206. Voices of SRNA Volunteers | Part 2

17:48

2024 Stronger Together | Raising Funds for Rare

17:56

2024 Stronger Together | Quality of Life Family Camp Information Session

15:47

2024 Stronger Together | Creative Connections: 30-Word Stories

41:57

2024 Stronger Together | Founders' Perspectives: A Conversation with SRNA Leaders

52:55

2024 Stronger Together | Journey Together: Reflecting and Shaping the Future

37:01

1205. Voices of SRNA Volunteers | Part 1

43:48

1204. Community Spotlight | Ilona Williams

22:01

102. Dr. Paula Barreras

42:59

1203. Community Spotlight | Rick Telander

29:16

501. Transitioning from Pediatric to Adult Care with NMOSD

02:13

SRNA | The Power of Community

22:34

1202. Increased Intracranial Pressure in Pediatric MOG Antibody Disease

32:00

2023 RNDS en Español | Tratamiento y manejo de los trastornos neuroinmunológicos poco frecuentes

27:33

1201. A Conversation about Grief and Loss with Lisa McDaniel

18:43

2023 RNDS en Español | Una conversación con nuestros aliados de la industria sobre apoyo y recursos

17:43

2023 RNDS en Español | Programas educativos y de apoyo de SRNA

24:57

2023 RNDS en Español | Entendiendo los ensayos clínicos en NMOSD y MOGAD

27:48

2023 RNDS en Español | Entendiendo los trastornos neuroinmunológicos poco frecuentes en niños

31:20

2023 RNDS en Español | ¿Qué es MOGAD y EMAD?

17:34

2023 RNDS en Español | ¿Qué son los trastornos en el espectro de neuromielitis óptica (NMOSD)?

26:53

2023 RNDS en Español | ¿Qué son la mielitis transversa (MT) y la mielitis flácida aguda (MFA)?

22:22

2023 RNDS en Español | El Sistema nervioso y el Sistema inmune 101

15:58

1115. A Conversation about Grief and Loss with Chris Lopardi

26:29

1114. Neurosarcoidosis and Rare Neuroimmune Disorders

44:39

2023 RNDS | Open Q&A Session

18:08

2023 RNDS | Rehabilitation and recovery

40:36

2023 RNDS | A conversation on disability and rare neuroimmune disorders

30:33

2023 RNDS | Cognition, depression, and rare neuroimmune disorders

22:48

2023 RNDS | Care for the caregivers

34:31

1113. Acute Treatments and Rare Neuroimmune Disorders

25:38

1112. Social Determinants of Health in Rare Neuroimmune Disorders

27:03

2023 RNDS | Transplantation of human glial restricted progenitor cells into patients with TM

28:07

2023 RNDS | AQP4/MOG tolerization research

32:09

2023 RNDS | Clinical trials in MOGAD, NMOSD, and more

25:56

2023 RNDS | Neuropathic pain research

33:47

2023 RNDS | Urological management in rare neuroimmune disorders

12:00

2023 RNDS | Q&A on Spinal Cord Injury

35:03

2023 RNDS | Symptom management panel

41:26

2023 RNDS | Deliberations on acute and long-term treatment guidance

32:58

2023 RNDS | Is it a relapse or recurrence?

46:56

2023 RNDS | Unlocking controversies around causation

49:28

2023 RNDS | Understanding a diagnosis of ADEM, AFM, MOGAD, NMOSD, ON, and TM

11:18

2023 RNDS | Welcome

24:17

405. Neuro-Ophthalmology and NMOSD

36:15

404. All Things Relapses

23:33

1111. Dr. Anderson's Fellowship Research

18:18

1110. Can Do MS: Take Charge and Coaching Series

15:35

403. I-CAN, A Study of Inebilizumab in Children with AQP4+ NMOSD

28:50

101. Drs. Kelsey Poisson and Camille Wilson

45:30

2023 AFM Together | Community Roundtable